Coffee Metabolites and Kidney Disease: Answers or More Questions?

Szczegóły
Comments

Tytuł:: Coffee Metabolites and Kidney Disease: Answers or More Questions?
Autorzy:: Cornelis MC; Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Burton-Freeman B; Department of Food Science and Nutrition, Center for Nutrition Research, Institute for Food Safety and Health, Illinois Institute of Technology, Chicago, Illinois.
Źródło:: Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2021 Nov; Vol. 16 (11), pp. 1615-1616. Date of Electronic Publication: 2021 Nov 04.
Typ publikacji:: Editorial; Comment
Język:: English
Imprint Name(s):: Publication: 2023- : Hagerstown, MD : Wolters Kluwer Health
Original Publication: Washington, D.C. : American Society of Nephrology, c2005-
MeSH Terms:: Coffee*/adverse effects
Kidney Diseases*/epidemiology
Humans ; Metabolomics
References:: Kanbay M, Siriopol D, Copur S, Tapoi L, Benchea L, Kuwabara M, Rossignol P, Ortiz A, Covic A, Afsar B: Effect of coffee consumption on renal outcome: A systematic review and meta-analysis of clinical studies. J Ren Nutr 31: 5–20, 2021.
Cornelis MC: Toward systems epidemiology of coffee and health. Curr Opin Lipidol 26: 20–29, 2015.
Rothwell JA, Madrid-Gambin F, Garcia-Aloy M, Andres-Lacueva C, Logue C, Gallagher AM, Mack C, Kulling SE, Gao Q, Praticò G, Dragsted LO, Scalbert A: Biomarkers of intake for coffee, tea, and sweetened beverages. Genes Nutr 13: 15, 2018.
He WJ, Chen J, Razavi AC, Hu EA, Grams ME, Yu B, Parikh CR, Boerwinkle E, Bazzano L, Qi L, Kelly TN, Coresh J, Rebholz CM: Metabolites associated with coffee consumption and incident chronic kidney disease. Clin J Am Soc Nephrol 16: 1620–1629, 2021.
Tajik N, Tajik M, Mack I, Enck P: The potential effects of chlorogenic acid, the main phenolic components in coffee, on health: A comprehensive review of the literature. Eur J Nutr 56: 2215–2244, 2017.
Mishima E: Gut microbiota and systemic uremic solute accumulation. In: Uremic Toxins and Organ Failure, edited by Saito H, Abe T, Singapore, Springer Nature, 2020, pp 41–51.
Xia J, Wang L, Ma Z, Zhong L, Wang Y, Gao Y, He L, Su X: Cigarette smoking and chronic kidney disease in the general population: A systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant 32: 475–487, 2017.
Sekula P, Goek O-N, Quaye L, Barrios C, Levey AS, Römisch-Margl W, Menni C, Yet I, Gieger C, Inker LA, Adamski J, Gronwald W, Illig T, Dettmer K, Krumsiek J, Oefner PJ, Valdes AM, Meisinger C, Coresh J, Spector TD, Mohney RP, Suhre K, Kastenmüller G, Köttgen A: A metabolome-wide association study of kidney function and disease in the general population. J Am Soc Nephrol 27: 1175–1188, 2016.
Li R, Zeng L, Xie S, Chen J, Yu Y, Zhong L: Targeted metabolomics study of serum bile acid profile in patients with end-stage renal disease undergoing hemodialysis. PeerJ 7: e7145, 2019.
Steinbrenner I, Schultheiss UT, Kotsis F, Schlosser P, Stockmann H, Mohney RP, Schmid M, Oefner PJ, Eckardt K-U, Köttgen A, Sekula P; German Chronic Kidney Disease Investigators: Urine metabolite levels, adverse kidney outcomes, and mortality in CKD patients: A metabolome-wide association study [published online ahead of print April 9, 2021]. Am J Kidney Dis.
Grams ME, Shafi T, Rhee EP: Metabolomics research in chronic kidney disease. J Am Soc Nephrol 29: 1588–1590, 2018.
Contributed Indexing:: Keywords: caffeine; coffee; kidney disease; metabolomics
Substance Nomenclature:: 0 (Coffee)
Entry Date(s):: Date Created: 20211105 Date Completed: 20211119 Latest Revision: 20230203
Update Code:: 20240105
PubMed Central ID:: PMC8729412
DOI:: 10.2215/CJN.12420921
PMID:: 34737202
: Opinia redakcyjna

Comment on: Clin J Am Soc Nephrol. 2021 Nov;16(11):1620-1629. (PMID: 34737201)

Informacja